Alkermes Announces Initiation of Phase 2 Clinical Study of ALKS 3831

Alkermes Announces Initiation of Phase 2 Clinical Study of ALKS 3831

Filed under: drug treatment centers in massachusetts

Alkermes plc (NASDAQ:ALKS) today announced the initiation of a phase 2 study of ALKS 3831 a novel oral atypical antipsychotic drug candidate designed to be a broad spectrum treatment for schizophrenia. The double-blind active-controlled … such as …
Read more on PharmiWeb.com (press release)

 

ARIAD Names Sarah J. Schlesinger, M.D. of Rockefeller University to Its Board

Filed under: drug treatment centers in massachusetts

ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that …
Read more on MarketWatch

 

Blazeman Foundation Provides 0000 to Produce Critical Protein Used in Lou

Filed under: drug treatment centers in massachusetts

Sometimes funding research is about determining if a particular protein can be produced in a cost-effective manner for treating patients. The ALS Research Group at Wake Forest Baptist Medical Center, led by researcher Carol Milligan, Ph.D …
Read more on Xtri.com

 


 

Drug and Alcohol Rehab – Massachusetts, Begin Recovery Today – http://www.drugrehabvideo.com Do you need drug and alcohol rehab and want to get out of Massachusetts? Get help with recovery today. Its time to start down t…